This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Report of a Case

W. E. CLENDENNING, M.D.; MORTON A. KRESS, M.D.; ELIZABETH W. RAUSCHKOLB, M.D.

Arch Dermatol. 1960;82(4):533-536.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

In 1958 a new phenothiazine derivative, trimeprazine,^* was introduced as a nonspecific oral agent for the treatment of pruritus. Preliminary studies indicated its usefulness in a wide variety of itching dermatoses which are, according to our present knowledge, unrelated etiologically. The mechanism of action is obscure. It does not appear to be directly related to its histamine antagonism or to its tranquilizing effect.¹ It may reduce the perception of itching by the central nervous system in an as yet undetermined fashion.

It has been recognized that phenothiazine derivatives can produce agranulocytosis since 1954, when the first case due to chlorpromazine was reported. Other toxic effects are epileptic seizures, symptoms mimicking parkinsonism, hepatitis, skin eruptions, and photosensitization. As each new derivative has appeared these toxic effects have occurred in varying percentages in all which have undergone any appreciable use.

Therefore, one would not expect trimeprazine to be the exception. . . . [Full Text PDF of this Article]

Author Affiliations
Cleveland

Resident in Dermatology (Dr. Clendenning), Assistant Resident in Dermatology (Dr. Kress), Assistant Resident in Dermatology (Dr. Rauschkolb), University Hospitals of Cleveland.

Footnotes
Submitted for publication Dec. 7, 1959.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?